Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Outline
- Mammalian antibody classes
- Schematic of IgG structure
- Kabat database variability of VH sequences
- Schematic of IgG domains
- Variable and complementarity determining regions
- Antibody variation
- Light chain expression
- Heavy chain expression
- Variable region features
- Mechanism of gene rearrangements
- Recombination signal sequences
- Mechanism and consequences of segment joining
- Junctional diversity
- Heavy chain class-switching
- Regulation of expression of IgM
- B-cell differentiation
- B cell differentiation and division
- Somatic hypermutation of V-regions
- Lymphocyte-specific enzymes
- T-cell receptors
- The T-cell antigen receptor complex
- T-cell receptor and MHC class I complex
- TCR chains are analogous to Ig H and L chains
- The theoretical Ig and TCR repertoire
- Conclusion
- Thank you for listening
Topics Covered
- Mammalian antibody classes
- Structure of antibodies
- Antibody variation
- Mechanisms that elevate the variability of antibodies
- B cell differentiation, division and somatic hypermutation
- The T-cell antigen receptor complex
- TCR chains are analogous to Ig H & L chains
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Clark, M. (2021, January 31). Antibody genes and diversity [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/YTPE3203.Export Citation (RIS)
Publication History
Financial Disclosures
- Requested.
Other Talks in the Series: The Immune System - Key Concepts and Questions
Transcript
Please wait while the transcript is being prepared...
0:00
Hi, my name is Dr. Mike Clark and I'm formerly a reader in
Therapeutic and Molecular Immunology in
the Department of Pathology at Cambridge University.
I retired in 2014.
What I want to do today is to give you an introductory lecture,
which was based on the lectures I used to give
undergraduates on antibody genes and diversity.
0:21
Essentially, there are two great problems that exist in immunology.
The first is before we encounter an infection,
the body has no idea what an infection is going to look like.
We may encounter bacteria, viruses,
all sorts of different antigens and pathogens that will try to invade our body.
We have no idea in which order they might invade our body or
what they are going to look like until we actually encounter them,
and so this generates a problem.
If you want a molecule such as an antibody to recognize this invading pathogen,
and yet you don't know what the pathogen is going to look like until it arrives.
You actually have to have a system in which you can generate
a huge diversity of different antigen receptors,
so different antibodies binding different target antigens.
This is the problem of generation of diversity,
so that's a major problem in the immune system.
But there is a second problem that arises because of that,
which is if we have a system that essentially is
capable of generating a very large number of
different receptors against an indefinite number of
antigens that you might encounter in some unpredictable fashion and order,
how do you prevent the situation whereby some of
those antibodies might react against yourself?
Because of course, when you're born,
you inherit genes from both your mother and from your father.
So until your body starts developing,
it doesn't have a concept of what antigens that might exist in your own body,
so until you actually start to express them
from the genes that you inherit from your parents,
you have no way of knowing what are the antigens present in your own body.
This creates a huge problem for the immune system.
You have the problem of, you have to have the ability to generate a huge number of
receptors that bind to all these foreign antigens that you might encounter,
but at the same time, you've got the problem that you might accidentally
generate antibodies and receptors that recognize your own body.
Now, in this lecture on antibody genes,
I'm going to tackle the question of the problem of generation of diversity,
but I'm going to leave it for other lectures in this series
who actually deal with the other problem of how do you
prevent autoreactivity because that is
a whole different question that would be very difficult to tackle in a single lecture.
In this lecture, I'm going to just deal with
the problem of generation of antibody diversity.
We'll see how that relates to
the structure and function of the antibody molecule is concerned,
and then it'll be left for other lectures in the series to
deal with how do you prevent that diversity reacting with self,
the auto-immune disease problem.